AstraZeneca’s Fasenra cleared in Europe (EU)
The European Commission (EC) has approved AstraZeneca’s Fasenra as an add-on maintenance treatment in certain adult patients with severe eosinophilic…
Pharmaceuticals, Biotechnology and Life Sciences
The European Commission (EC) has approved AstraZeneca’s Fasenra as an add-on maintenance treatment in certain adult patients with severe eosinophilic…
Amryt has paved its way for marketing for Lojuxta by signing a deal with with GryNumber Health. The exclusive distribution…
Basilea Pharmaceutica and Pfizer have extended their license agreement for Basilea’s antifungal Cresemba to China and sixteen countries in Asia…
Vertex Pharmaceuticals got European Commission’s grant to extend the Marketing Authorization for ORKAMBI, the first medicine to treat the basic…
Novartis has initiated SURPASS, a head-to-head clinical trial of Cosentyx (secukinumab) versus proposed biosimilar adalimumab in ankylosing spondylitis (AS). SURPASS…
BASF Care Creations and the Cell Therapy Research Institute CTIBiotech presented the initial results of their joint research on 3D…
LSS Labelling Systems Scandinavia, a Denmark-based supplier of labelling solutions will launch a new Tamper Evident labelling machine for the pharmaceutical industry at…
BD has started an offer to repurchase all of its outstanding 3.000% Notes until May 15, 2026 that were issued…
Amryt, a biopharmaceutical company focused on rare and orphan diseases, has signed an agreement for distributing its Lojuxta through RCC…
Sanofi and Regeneron Pharmaceuticals said they will accelerate and expand investment for the clinical development of the PD-1 (programmed cell…